ChemicalBook >> CAS DataBase List >>Atomoxetine hydrochloride

Atomoxetine hydrochloride

CAS No.
82248-59-7
Chemical Name:
Atomoxetine hydrochloride
Synonyms
ATOMOXETINE;Strattera;ATOMOXETINE HCL;ATOMOXITINE;Atomoxetine HCI;LY 139603;LY 139603 HCl;Atazanavir HCl;Atomoxitine HCL;(R)-Atomoxetine HCl
CBNumber:
CB5757860
Molecular Formula:
C17H22ClNO
Molecular Weight:
291.82
MDL Number:
MFCD06410992
MOL File:
82248-59-7.mol
MSDS File:
SDS
Last updated:2024-11-19 15:53:33

Atomoxetine hydrochloride Properties

Melting point 167-169°C
alpha D25 -38.01°; 36525 -177.26° (c = 1 in methanol); D23 -41.37° (c = 1.02 in methanol); D25 -40.3° (c = 0.94 in ethanol)
Flash point 9℃
storage temp. 2-8°C
solubility soluble in Methanol
form solid
pka 10.13(at 25℃)
color White to Almost white
Water Solubility Soluble to 50 mM in water with gentle warming
Merck 14,863
BCS Class 1?
InChI InChI=1/C17H21NO.ClH/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15;/h3-11,17-18H,12-13H2,1-2H3;1H/t17-;/s3
InChIKey LUCXVPAZUDVVBT-UNTBIKODSA-N
SMILES O([C@H](CCNC)C1C=CC=CC=1)C1=CC=CC=C1C.Cl |&1:1,r|
CAS DataBase Reference 82248-59-7(CAS DataBase Reference)
FDA UNII 57WVB6I2W0
NCI Drug Dictionary atomoxetine hydrochloride

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictogramsGHS hazard pictogramsGHS hazard pictograms
GHS02,GHS06,GHS08
Signal word  Danger
Hazard statements  H225-H301+H311+H331-H370
Precautionary statements  P210-P260-P280-P301+P310-P311
Hazard Codes  F,T
Risk Statements  11-23/24/25-39/23/24/25
Safety Statements  22-24/25-45-36/37-16-7
RIDADR  UN1230 - class 3 - PG 2 - Methanol, solution
WGK Germany  3
HS Code  29221990
NFPA 704
0
4 0

Atomoxetine hydrochloride price More Price(41)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich A-095 Atomoxetine hydrochloride solution 1.0?mg/mL in methanol (as free base), ampule of 1?mL, certified reference material, Cerilliant? 82248-59-7 1mL $183 2024-03-01 Buy
TCI Chemical A2357 Atomoxetine Hydrochloride >98.0%(HPLC)(T) 82248-59-7 100mg $90 2024-03-01 Buy
TCI Chemical A2357 Atomoxetine Hydrochloride >98.0%(HPLC)(T) 82248-59-7 1g $511 2024-03-01 Buy
Cayman Chemical 22248 Atomoxetine (hydrochloride) 82248-59-7 5mg $73 2024-03-01 Buy
Cayman Chemical 22248 Atomoxetine (hydrochloride) 82248-59-7 50mg $431 2024-03-01 Buy
Product number Packaging Price Buy
A-095 1mL $183 Buy
A2357 100mg $90 Buy
A2357 1g $511 Buy
22248 5mg $73 Buy
22248 50mg $431 Buy

Atomoxetine hydrochloride Chemical Properties,Uses,Production

Description

Atomoxetine is the first non-stimulant marketed for the treatment of attention deficit hyperactivity disorder (ADHD). It is the R-stereoisomer of the racemate tomoxetine and is a selective and potent norepinephrine uptake inhibitor (Ki=0.7–1.9 nM) that is devoid of binding to monoamine receptor. It also has little effect on dopamine and serotonin reuptake or acetylcholine, H1 histamine, alpha1 or alpha1-adrenergic or dopamine receptors. It is prepared from racemic 1-phenylbut-3-en-1-ol via a selective enzymatic acylation leaving the desired S-stereoisomer as the alcohol. This alcohol is converted via a Mitsunobu reaction with ortho-cresol to the corresponding ether with isomeric R-configuration. Ozonolysis and reduction steps provided the terminal alcohol that is mesylated and displaced with methylamine. Its selectivity for norepinephrine relative to dopamine inhibition was demonstrated in vivo preclinically. In a two-lever (two condition) discriminative stimulus effect study in squirrel monkeys, tomoxetine and other norepinephrine uptake inhibitors substituted for cocaine under low-dose training conditions, whereas dopamine uptake inhibitors substituted for cocaine in both low and high-dose conditions. In clinical ADHD studies in adolescents, it was significantly different from placebo in 1.2 and 1.8 mpk/day dosing. In the clinical study in adults using the CAARS scale a 95 mg/day dose provided greater than 30% improvement in total scores. Atomoxetine is about 63% orally bioavailable, is highly protein bound (98%, primarily to albumin) and has a half-life of about 5.2 h. It is metabolized by CYP2D6 resulting in differential clearance for poor metabolizers (halflife of 19 h with a 10 times higher AUC) relative to extensive metabolizers. The total daily dose for children, adolescents and adults is a maximum of 100 mg/day. Common side effects in children and adults include nausea, decreased appetite, and dizziness. Adults may also have insomnia.

Description

Atomoxetine is a selective norepinephrine reuptake inhibitor with Ki values of 5, 77, and 1,451 nM for norepinephrine, serotonin, and dopamine transporters, respectively. It is selective over the choline, GABA, and adenosine transporters, and a number of neurotransmitter receptors, ion channels, second messengers, and brain/gut peptides. In the rat prefrontal cortex (PFC), it increases extracellular norepinephrine and dopamine by 3-fold and increases Fos expression. Atomoxetine (0.1, 0.5, and 1 mg/kg) reduces premature responding, a measure of impulsivity, by rats in the 5-choice serial reaction time test (5CSRTT) in a dose-dependent manner. It also has neuroprotective effects when administered prior to ischemic damage in a gerbil model of transient cerebral ischemia. Formulations containing atomoxetine have been used in the treatment of attention-deficit hyperactivity disorder (ADHD) in children, adolescents, and adults.

Chemical Properties

White Solid

Originator

Eli Lilly & Co (US)

Uses

(R)-Tomoxetine hydrochloride has been used as a noradrenaline reuptake inhibitor:

  • to study the role of L-threo-3,4-dihydroxyphenylserine (L-DOPS) in the pathogenesis of Alzheimer′s disease in mice
  • to study its effects on set shifting in rats
  • to study its effects on rat brain as a result of its long-term use

Uses

Atomoxetine hydrochloride, a Norepinephrine reuptake inhibitor, is used as a Psychotherapeutic and anti-depressant. These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications, including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. Atomoxetine hydrochloride may be used as a pharmaceutical reference standard for determining atomoxetine hydrochloride in pharmaceutical formulations by spectrophotometric method.

Definition

ChEBI: The hydrochloride salt of atomoxetine.

brand name

Strattera (Lilly).

General Description

Atomoxetine hydrochloride is a nonstimulant used in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adults.

Biological Activity

Potent and selective noradrenalin re-uptake inhibitor (K i values are 5, 77 and 1451 nM for inhibition of radioligand binding to human NET, SERT and DAT respectively). Displays minimal affinity for a range of other neurotransmitter receptors and transporters (K i > 1 μ M). Antidepressant.

Biochem/physiol Actions

Norepinephrine uptake blocker.

Synthesis

The 3-aryloxy substituent was introduced utilizing a chiral alcohol by either the Mitsunobu reaction or by nucleophilic aromatic displacement. Because of the expense and difficulty of the Mitsunobu reaction on large scale, the commercial process adopts the nucleophilic aromatic substitution method. 3- Chloropropiophenone (37) was asymmetrically reduced with borane and catalytic amount of (S)-oxazaborolidine (8) in THF at 0??C to give chiral alcohol 38 in 99% yield and 94% e.e. The chiral alcohol was further purified by recrystallization to greater than 99% e.e.. Subsequent treatment of chloride 38 with excess dimethylamine (40% in water) in ethanol gave dimethylamine alcohol 39 in 90% yield. Alcohol 39 was then subjected to nucleophilic aromatic displacement in the presence of NaH in DMSO with 1- fluoro-2-(t-butylimino)benzene (41), which was prepared in high yield from 2-fluorobenzaldehyde (40). The displacement product 42 was obtained in 98% yield, and the imine 42 was subsequently hydrolyzed with acetic acid in water at low temperature to give the corresponding aldehyde 43 in 96% yield. Sodium borohydride was employed to reduce aldehyde 43 to alcohol in cold methanol and the intermediate alcohol was converted to chloride 44 with thionyl chloride. Chloride 44 was then reduced with zinc metal under acidic conditions to give methyl adduct 45 in 95% yield and 94% e.e. Finally, phenyl chloroformate and triethylamine was used to transform dimethylamine 45 to monomethyl amine, which was subsequently treated with HCl in EtOAc under reflux to give atomoxetine hydrochloride (IV) in 98% yield and 99% e.e. from 45.Synthesis_82248-59-7

storage

Store at RT

Clinical claims and research

Atomoxetine hydrochloride was assessed in four randomized, double-blind, placebo-controlled studies involving 759 paediatric patients (ages 6 to 18 years old) who met the Diagnostic and Statistical Manual 4th edition (DSM-IV) criteria for ADHD. Signs and symptoms of ADHD were evaluated by a comparison of mean change from baseline to endpoint for atomoxetine hydrochloride-treated and placebo-treated patients using an intent-to-treat analysis of the primary outcome measure, the investigator-administered and -scored ADHD Rating Scale-IV-Parent Version (ADHDRS) total score. In all four trials, which lasted six to nine weeks, improvements in ADHD symptoms were significantly superior in patients receiving atomoxetine hydrochloride compared with those receiving placebo. Atomoxetine hydrochloride was also studied in two randomized, double-blind, placebo-controlled studies involving 536 adult patients who met DSM-IV criteria for ADHD. Signs and symptoms were evaluated using the investigator-administered Conners Adult ADHD Rating Scale Screening Version (CAARS). In both studies, which lasted ten weeks, ADHD symptoms were significantly improved in those patients receiving atomoxetine hydrochloride[1].

References

[1] Melissa Garland, Peter Kirkpatrick. “Atomoxetine hydrochloride.” Nature Reviews. Drug Discovery 3 5 (2004): 385–386.

615-37-2
115290-81-8
82248-59-7
Synthesis of Atomoxetine hydrochloride from 2-Iodotoluene and (R)-(+)-3-(N-METHYLAMINO)-1-PHENYL-1-PROPANOL

Atomoxetine hydrochloride Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 525)Suppliers
Supplier Tel Email Country ProdList Advantage
S&Y Biochem Co.,Ltd
+8617774091612 marketing@sybiochem.com China 128 58
Hebei Weibang Biotechnology Co., Ltd
+8615531157085 abby@weibangbio.com China 8808 58
Hebei Mojin Biotechnology Co., Ltd
+86 13288715578 +8613288715578 sales@hbmojin.com China 12834 58
XI'AN TIANGUANGYUAN BIOTECH CO., LTD.
+86-029-86333380 18829239519 sales06@tgybio.com China 901 58
Hebei Weibang Biotechnology Co., Ltd
+8617732866630 bess@weibangbio.com China 18150 58
Hebei Mojin Biotechnology Co.,Ltd
+86-15028179902 angelia@hbmojin.com China 1176 58
Capot Chemical Co.,Ltd.
+86-(0)57185586718 +86-13336195806 sales@capot.com China 29791 60
Beijing Cooperate Pharmaceutical Co.,Ltd
010-60279497 sales01@cooperate-pharm.com CHINA 1803 55
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512 info@tianfuchem.com China 21634 55
Shanxi Naipu Import and Export Co.,Ltd
+86-13734021967 +8613734021967 kaia@neputrading.com China 1001 58

View Lastest Price from Atomoxetine hydrochloride manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Atomoxetine Hydrochloride pictures 2024-12-23 Atomoxetine Hydrochloride
82248-59-7
US $0.00 / Kg/Bag 2Kg/Bag 99% up, High Density 20 tons Sinoway Industrial co., ltd.
Atomoxetine hydrochloride pictures 2024-12-16 Atomoxetine hydrochloride
82248-59-7
US $1.00 / kg 1kg 99 100 S&Y Biochem Co.,Ltd
Atomoxetine hydrochloride pictures 2024-11-19 Atomoxetine hydrochloride
82248-59-7
US $54.00-40.00 / mg 99.8% 10g TargetMol Chemicals Inc.

Atomoxetine hydrochloride Spectrum

ATOMOXETINE HYDROCHLORIDE METHYL-(3-PHENYL-3-O-TOLYLOXY-PROPYL)-AMINE HYDROCHLORIDE (R)-N-METHYL-GAMMA-(2-METHYLPHENOXY)-BENZENEPROPANAMINE HYDROCHLORIDE (r)-tomoxetine hydrochloride TOMOXETINE HYDROCHLORIDE (R)-N-methyl-gamma-(2-methylphenoxy)-benzenepropanamine (R)-N-Methyl-g-(2-methylphenoxy)benzenepropanaminehydrochloride R-Tomexetine, Hydrochloride, (R)-N-Methyl--(2-methylphenoxy)benzenepropanamine, Hydrochloride (r)-n-methyl-γ-(2-methyl-phenoxy)benzenepropanamine hydrochloride ATOMOXETINEHYDROCHLORIDE(FORR&DONLY) Atomexine Hydrochloride Atomoxetine hydrochloride, (R)-N-Methyl-γ-(2-methylphenoxy)benzenepropanamine hydrochloride Atomoxitine HCL LY 139603 R-Tomexetine Hydrochloride (3R)-N-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine hydrochloride (3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine hydrochloride methyl-[(3R)-3-(2-methylphenoxy)-3-phenyl-propyl]amine hydrochloride BenzenepropanaMine,N-Methyl-g-(2-Methylphenoxy)-,hydrochloride ( (R)-N-Methyl-3-(2-methylphenoxy)-3-phenylpropylamine Hydrochloride (R)-Tomoxetine Hydrochloride (R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-aMine hydrochloride BenzenepropanaMine,N-Methyl-g-(2-Methylphenoxy)-,hydrochloride (1:1), (gR)- (R)-N-Methyl-3-phenyl-3-(o-tolyloxy)-propan-1-aMine hydrochloride, 95+% LY 139603 HCl Atomoxetine hydrochloride (R)-Tomoxetine hydrochloride (R)-Atomoxetine hydrochloride Atomoxetine for impurity A identification Atomoxetine hydrochloride solution Atomoxetine Hydrochloride (125 mg) Atomoxetine Hydrochloride Impurity Benzenepropanamine,N-methyl-g-(2-methylphenoxy)-,hydrochloride,(R)- Atomoxetine Hydrochloride IMP (R)-N-Methyl-3-(2-methylphenoxy)-3-phenylpropylamine Hydrochloride Methyl-((R)-3-phenyl-3-o-tolyloxy-propyl)-amine hydrochloride Atomoxetine hydrochloride, 99%, a selective norepinephrine reuptake inhibitor (R)-N-METHYL-3-PHENYL-3-(O-TOLYLOXY)PROPAN-1-AMINE HCL Atazanavir HCl Atomoxetine hydrochloride CRS Atomoxetine Hydrochloride > (R)-Atomoxetine HCl Atomoxetine hydrochloride USP/EP/BP Tomoxetine hydrochloride impurity Atomoxetine HCl (Tomoxetine Atomoxetine HydrochlorideQ: What is Atomoxetine Hydrochloride Q: What is the CAS Number of Atomoxetine Hydrochloride Q: What is the storage condition of Atomoxetine Hydrochloride Q: What are the applications of Atomoxetine Hydrochloride (R)-(-)-Atomoxetine-D5 HCl Atomoxetine Hydrochloride (1044469) ATOMOXETINE ATOMOXETINE HCL Atomoxetine HCI ATOMOXITINE Strattera (R)-N-methyl-N-(3-phenyl-3-(o-tolyloxy)propyl)formamide Atomoxetine Impurity 7 HCl Atomoxetine hydrochloride hcl 2H7]-Atomoxetine HCl (Racemic) Atomoxetine hydrochloride in methanol 82248-59-7 C17H21NOClH